Hartman, M.L.; Rogut, M.; Mielczarek-Lewandowska, A.; Wozniak, M.; Czyz, M.
17-Aminogeldanamycin Inhibits Constitutive Nuclear Factor-Kappa B (NF-κB) Activity in Patient-Derived Melanoma Cell Lines. Int. J. Mol. Sci. 2020, 21, 3749.
https://doi.org/10.3390/ijms21113749
AMA Style
Hartman ML, Rogut M, Mielczarek-Lewandowska A, Wozniak M, Czyz M.
17-Aminogeldanamycin Inhibits Constitutive Nuclear Factor-Kappa B (NF-κB) Activity in Patient-Derived Melanoma Cell Lines. International Journal of Molecular Sciences. 2020; 21(11):3749.
https://doi.org/10.3390/ijms21113749
Chicago/Turabian Style
Hartman, Mariusz L., Magdalena Rogut, Aleksandra Mielczarek-Lewandowska, Michal Wozniak, and Malgorzata Czyz.
2020. "17-Aminogeldanamycin Inhibits Constitutive Nuclear Factor-Kappa B (NF-κB) Activity in Patient-Derived Melanoma Cell Lines" International Journal of Molecular Sciences 21, no. 11: 3749.
https://doi.org/10.3390/ijms21113749
APA Style
Hartman, M. L., Rogut, M., Mielczarek-Lewandowska, A., Wozniak, M., & Czyz, M.
(2020). 17-Aminogeldanamycin Inhibits Constitutive Nuclear Factor-Kappa B (NF-κB) Activity in Patient-Derived Melanoma Cell Lines. International Journal of Molecular Sciences, 21(11), 3749.
https://doi.org/10.3390/ijms21113749